Transplacental transfer of aflatoxin in humans

David W. Denning*, Roger Allen, Andrew P. Wilkinson, Michael R.A. Morgan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

This study quantified aflatoxin (AFB1, AFG1 and AFQ1) by enzyme-linked immunosorbent assay in human cord sera obtained at birth and in serum obtained immediately after birth from the mother. The subjects of the study were residents of Songkhla, Thailand. Of the 35 samples of cord sera, 17 (48%) contained aflatoxin in concentrations from 0.064 to 13.6, mean 3.1 nmol/ml. By comparison only two (6%) of 35 maternal sera contained aflatoxin (mean 0.62 nmol/ml). These results demonstrate transplacental transfer and concentration of aflatoxin by the feto-placental unit which may be of biological importance. Aflatoxins are mutagenic, carcinogenic and teratogenic and cause immuno-suppression in animals. The implications of these findings are potentially profound and deserve further study.

Original languageEnglish
Pages (from-to)1033-1035
Number of pages3
JournalCarcinogenesis
Volume11
Issue number6
DOIs
Publication statusPublished - 1 Jun 1990

Fingerprint

Dive into the research topics of 'Transplacental transfer of aflatoxin in humans'. Together they form a unique fingerprint.

Cite this